The study and its comparison
A trial randomized 107 Mongolian children aged two to seventeen with winter-related atopic dermatitis to 1,000 IU vitamin D daily or placebo for one month. All families received emollient and skin-care education; 104 children completed follow-up. [1]
Eczema severity scores improved by about 6.5 versus 3.3 points, favoring vitamin D. Investigator global assessment also favored supplementation. [1]
What the finding establishes
One month in a population considered likely to have low vitamin D does not establish benefit for every eczema patient or season. No reported adverse events cannot prove long-term safety. Funding and conflicts were not established from the abstract. The study tested supplementation alongside basic skin care, not replacement of that care. [1]
A hypothetical distinction
Imagine both trial groups receive emollients. The added intervention must be interpreted on top of that shared treatment.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.